The SyncroPatch 384 is installed at the FDA for cardiac safety pharmacology studies
Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (…
Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (…
April 17th 2020: Nanion Technologies GmbH, a leading provider of automated patch clamp and cell monitoring systems, anno…
Transporter proteins are gaining increasing interest in academic science and as therapeutic targets. Nanion’s two platfo…